Key Considerations for Co-developing Therapeutics and Companion Diagnostics

Webinar: Principles for Co-development of In-Vitro Companion Diagnostic Device w Therapeutic ProductПодробнее

FDA Guidance on Co-Development of Therapeutics and Companion DiagnosticsПодробнее

Key Considerations for the Pre-clinical Development of Therapeutic InnovationsПодробнее

Regulatory Peculiarities: Combination Products and Companion DiagnosticsПодробнее

Considerations for Companion Diagnostics: Lessons Learned and Key Takeaways from DIA 2024Подробнее

Planning for Co-development of Companion DiagnosticsПодробнее

Keynote Presentation: A Regulatory Perspective on Molecular Diagnostic DevicesПодробнее

Janice Au-Young - Companion Diagnostics Co-Development: Are you ready?Подробнее

Advancing the Use of Biomarkers and Pharmacogenomics in Drug DevelopmentПодробнее

Strategies for Companion Diagnostic DevelopmentПодробнее

Biomarker Based Companion Diagnostics Are Enabling Precision OncologyПодробнее

Andy Sutton - Distilling key data: the role of companion diagnosticsПодробнее

Bio-Techne - Together Transforming Companion DiagnosticsПодробнее

Appropriate Use of Companion Versus Complementary DiagnosticsПодробнее

Panel Discussion: Co-development of Drugs and Companion DiagnosticsПодробнее

The biomarker to companion diagnostic continuum a road map for the delivery of precision medicineПодробнее

Companion DiagnosticsПодробнее

Advancing Oncology Care: The Evolving Role of Diagnostic Labs in Biomarker-Driven TherapiesПодробнее

Companion Diagnostics Webinar RecordingПодробнее

Genomenon Pharma Webinar | Genomic Biomarker Selection for Companion Diagnostic DevelopmentПодробнее

Companion Diagnostic Approaches in the Development of Cell and Gene TherapiesПодробнее

Companion Diagnostics Market | Exactitude Consultancy ReportsПодробнее

Oncology Companion Diagnostics Market 2025: Trends, Key Players & Growth InsightsПодробнее